Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Bronx, New York Clinical Trials

A listing of Bronx, New York clinical trials actively recruiting patient volunteers.

RESULTS

Found (6) clinical trials

Break the Cycle: Prevention for Reducing Initiation Into Injection Drug Use

Break the Cycle is a two-session, one-on-one, in-person intervention study designed to reduce the role persons who inject drugs (PWID) play initiating non-PWID into injection drug use. Study implementation is at two sites: New York City and Tallinn, Estonia. At baseline, quantitative data are collected via a structured computer-assisted personal ...

Phase N/A

2.42 miles

Learn More »

This randomized phase III trial compares topical or ablative treatment with active monitoring in preventing anal cancer in patients with human immunodeficiency virus (HIV) and high-grade squamous intraepithelial lesions (HSIL). Anal HSIL is tissue in the anal canal that has been damaged by infection with human papillomavirus (HPV) and is ...

Phase

4.81 miles

Learn More »

The 15-006 study is looking at an investigational medication to see how safe it is, and how well it works, in treating cataplexy and excessive daytime sleepiness in people who have narcolepsy with cataplexy. The study will last up to 22 weeks. All study-related medication and assessments will be provided ...

Phase

5.1 miles

Learn More »

A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients with Type 2 Diabetes Mellitus

Phase

6.14 miles

Learn More »

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Oral Solabegron Immediate Release Tablets in the Treatment of Overactive Bladder (OAB) in Adult Female Subjects

Phase

6.14 miles

Learn More »

A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control on Basal Insulin Alone or in Addition to Oral Antidiabetes Drugs (OADs)

Phase

6.14 miles

Learn More »